Vanguard Group Inc. grew its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 3.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,997,973 shares of the company's stock after buying an additional 586,626 shares during the period. Vanguard Group Inc. owned 7.68% of Oscar Health worth $255,333,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. KBC Group NV raised its stake in Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after acquiring an additional 2,555 shares during the period. ORG Wealth Partners LLC purchased a new stake in shares of Oscar Health during the 4th quarter valued at approximately $100,000. Alberta Investment Management Corp bought a new position in Oscar Health in the 4th quarter worth approximately $138,000. Virtu Financial LLC purchased a new position in Oscar Health in the 4th quarter valued at approximately $140,000. Finally, SMART Wealth LLC purchased a new stake in shares of Oscar Health during the fourth quarter worth $180,000. Institutional investors own 75.70% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on OSCR. Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price objective for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price target on the stock. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $20.21.
Read Our Latest Stock Analysis on Oscar Health
Oscar Health Price Performance
OSCR stock traded up $0.86 during mid-day trading on Wednesday, hitting $12.58. The company had a trading volume of 7,380,836 shares, compared to its average volume of 3,852,182. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.15 billion, a price-to-earnings ratio of -628.69 and a beta of 1.75. Oscar Health, Inc. has a 12-month low of $11.30 and a 12-month high of $23.79. The company has a 50-day moving average price of $14.16 and a 200 day moving average price of $15.48.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Oscar Health Company Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.